At the molecular level, TCS is characterized by a higher prevalence of BRAF and TERT mutations, RET/PTC3 rearrangements, and overexpression of c-MET, p53, and MUC1 than classical subtypes (4, 29). The gene discussed is MET; the disease is Treacher-Collins syndrome.